OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 39 citing articles:

Polycystic ovary syndrome: pathophysiology and therapeutic opportunities
Jiawen Dong, Aled Rees
BMJ Medicine (2023) Vol. 2, Iss. 1, pp. e000548-e000548
Open Access | Times Cited: 15

The Potential of SGLT-2 Inhibitors in the Treatment of Polycystic Ovary Syndrome: The Current Status and Future Perspectives
Dejana Rakic, Vladimir Jakovljević, Nikola Jović, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 998-998
Open Access | Times Cited: 12

Comparative Effectiveness of Antidiabetic Drugs as an Additional Therapy to Metformin in Women with Polycystic Ovary Syndrome: A Systematic Review of Metabolic Approaches
Maryam Heidarpour, Mehrzad Mojarad, Sadegh Mazaheri‐Tehrani, et al.
International Journal of Endocrinology (2024) Vol. 2024, pp. 1-11
Open Access | Times Cited: 4

MODERN ASPECTS OF TREATMENT OF WOMEN WITH POLYCYSTIC OVARY SYNDROME
Halyna Semenyna
GRUNDLAGEN DER MODERNEN WISSENSCHAFTLICHEN FORSCHUNG (2023)
Open Access | Times Cited: 2

Controlled attenuation parameters to assess liver steatosis in obese patients with polycystic ovary syndrome
Dongxu Wang, Nan Nan, Hao Bing, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 2

Effect of SGLT2 Inhibitors on Improving Glucolipid Metabolism and Reproductive Hormone Status in Overweight/Obese Women with PCOS: A Systematic Review and Meta-Analysis
Lanlan Zhang, Zun Wang, Lingnan Kong, et al.
Reproductive Sciences (2023) Vol. 31, Iss. 5, pp. 1190-1203
Closed Access | Times Cited: 2

The Role of Sodium-Glucose Cotransporter-2 Inhibitors in the Treatment of Polycystic Ovary Syndrome: A Review
Rachel Porth, Karina Oelerich, Mala S. Sivanandy
Journal of Clinical Medicine (2024) Vol. 13, Iss. 4, pp. 1056-1056
Open Access

Research Progress of Sodium-Glucose Cotransporter 2 Inhibitor in the Treatment of Polycystic Ovary Syndrome
玺印 岳
Advances in Clinical Medicine (2024) Vol. 14, Iss. 02, pp. 4573-4580
Closed Access

Uso de metformina na redução da resistência à insulina e sintomas associados a síndrome do ovário policístico (SOP)
Matheus Lira dos Santos, Genildo da Silva Neto, Rodolfo Rodrigues de Carvalho, et al.
Brazilian Journal of Health Review (2024) Vol. 7, Iss. 1, pp. 3054-3058
Open Access

Benefícios cardiovasculares relacionados ao uso de fármacos inibidores da proteína SGLT-2
Matheus Leite Ferreira, Vanessa Erika Abrantes Coutinho, Mayara Furtado Araújo da Silva, et al.
Research Society and Development (2024) Vol. 13, Iss. 3, pp. e10113345349-e10113345349
Open Access

Update on the clinical applications of SGLTis: Insight to benefits beyond hypoglycemic and cardiorenal protection
Shibing Tao, S. Guo, Nanwei Tong
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2024) Vol. 44, Iss. 8, pp. 642-657
Closed Access

Exploring the Evolving Role of SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Managing Cardiovascular Injury Induced by Obesity: Spotlight on ROS as a Key Mediator
Lara Srour, Jaafar Ismail, Rachel Njeim, et al.
Oxidative stress in applied basic research and clinical practice (2024), pp. 207-226
Closed Access

O IMPACTO DAS NITROSAMINAS NO CENÁRIO FARMACÊUTICO: CONTAMINAÇÃO EM MEDICAMENTOS E A AÇÃO DA VIGILÂNCIA SANITÁRIA
Layane de Sousa Lima, Samara Oliveira Pinto, Hellen Dinne de Souza do Nascimento
(2024), pp. 86-95
Open Access

AUTOMEDICAÇÃO E USO RACIONAL DE MEDICAMENTOS: A IMPORTÂNCIA DO FARMACÊUTICO NA AUTOMEDICAÇÃO E PROMOÇÃO DO USO RACIONAL DE MEDICAMENTOS
Aldineia de Jesus Ximenes, Euvania Zarliene dos Santos Pereira, Larissa Souza Reis, et al.
(2024), pp. 22-33
Open Access

OS BENEFÍCIOS DA OZONIOTERAPIA EM PACIENTES PÓS COVID-19
Sabrina Iris da Silva, Rosangela Lins Alves Lima
(2024), pp. 67-76
Open Access

USO DE PLANTAS MEDICINAIS COMO ALTERNATIVA PARA TRATAMENTO DE QUADROS DE SINUSITE: UMA REVISÃO DE LITERATURA
Délio Henrique Vieira da Silva, Michael Marcione Silva, Cristiane Gomes Lima
(2024), pp. 41-53
Open Access

ZOLPIDEM: TRATAMENTO FARMACOLÓGICO PARA ALTERAÇÕES DO SONO E O PAPEL DO FARMACÊUTICO CLÍNICO NO TRATAMENTO
Elizelma Oliveira Silva, Lucas Lopes Menezes, Samuel da Silva Santos, et al.
(2024), pp. 1-7
Open Access

PLANTAS MEDICINAIS PARA O TRATAMENTO DA DEPRESSÃO: PLANTAS FITOTERÁPICAS
Amanda Oliveira de Aguiar, Emily dos Santos Carvalho, R. M. da Silva, et al.
(2024), pp. 34-40
Open Access

O USO DE PRODUTOS NATURAIS DA AMAZÔNIA EM COSMETOLOGIA
Ailime Lobato Picanço de Melo, Pâmela Beatriz Gomes Mamede, Maria Cristina Vasconcellos, et al.
(2024), pp. 122-139
Open Access

A EFICÁCIA DA ESPIRAMICINA NO TRATAMENTO DA TOXOPLASMOSE CONGÊNITA
Robson Alfredy, Tania Rocha, Beatriz Camargo
(2024), pp. 108-121
Open Access

A IMPORTÂNCIA DA ASSISTÊNCIA FARMACÊUTICA NA SAÚDE DO IDOSO USUÁRIO DE POLIFARMÁCIA
Maria Elizabeth Neres de Sousa, Isaias de Sousa Oliveira, Bruno Gedeon de Araújo
(2024), pp. 54-66
Open Access

MALEFÍCIOS DO USO INDISCRIMINADO DO FENTANIL COMO DROGA RECREATIVA
Danyelly Araujo Alves, Kelvin dos Santos Veras, Anna Maly de Leão e Neves Eduardo, et al.
(2024), pp. 15-21
Open Access

Page 1 - Next Page

Scroll to top